Propranolol Hydrochloride

318-98-9 Categories: , ,
  • # LGM Pharma is a Propranolol Hydrochloride CAS# 318-98-9 API supplier distributor based in the USA. Inquire about DMF, cGMP, price, availability, samples, sourcing, purity and more.
  • # Questions? Call our customer API support number 1-(800)-881-8210.
  • # LGM Pharma offers this active ingredient but not the finished dosage forms.
  • Inquire about this product >>

Product Details:

  • Product Name: Propranolol Hydrochloride
  • CAS #: 318-98-9
  • Mode of Action:

    Propranolol competes with sympathomimetic neurotransmitters such as catecholamines for binding at beta(1)-adrenergic receptors in the heart, inhibiting sympathetic stimulation. This results in a reduction in resting heart rate, cardiac output, systolic and diastolic blood pressure, and reflex orthostatic hypotension.

  • Pharmacodynamics:

    Propranolol, the prototype of the beta-adrenergic receptor antagonists, is a competitive, nonselective beta-blocker similar to nadolol without intrinsic sympathomimetic activity. Propanolol is a racemic compound; the l-isomer is responsible for adrenergic blocking activity.

  • Metabolism:


  • Toxicity:

    Symptoms of overdose include bradycardia, cardiac failure, hypotension, and brochospasm. LD50=565 mg/kg (orally in mice).

  • IUPAC: (RS)-1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol
  • ATC: C07AA05
  • PubChem: 4946
  • DrugBank: DB00571
  • Formula: C16H21N1O2
  • Molecular Mass: 259.34
  • Synonyms: (+-)-1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol hydrochloride, 1-(1-Naphthyloxy)-2-hydroxy-3-isopropylaminopropane hydrochloride, 1-(Isopropylamino)-3-(1-naphthoxy)-propan-2-ol hydrochloride, 1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol hydrochloride, 1-(Isopropylamino)-3-(alpha-naphthoxy)-2-propanol hydrochloride, 1-Isopropylamino-3-(1-naphthoxy)-propan-2-ol-hydrochloride, 2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)-, hydrochloride, 2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)-, hydrochloride, (+-)-, Acifol, Anaprilin, Anapriline, Angilol, Apsolol, Arcablock, Artensol, Avlocardyl, AY 64043, Beprane, Berkolol, beta Neg, beta-NEG, Beta-Tablinen, Beta-Timelets, Biocard, Blocaryl, Cardinol, Caridolol, CCRIS 1105, Cinlol, Ciplar, Corbeta, d,l-Propranolol hydrochloride, Deralin, Detensol, Dibudinate, DL-Anapriline, DL-Propranolol hydrochloride, Dociton, Dumopranol, Duranol, Duraprox, Efectolol, EINECS 206-268-7, EINECS 222-501-5, Elbrol, Emforal, Farprolol, Frekven, Half-Inderal, HemangeolHemangeol, Hemipralon, Herzbase, Herzul, HSDB 3176, I 2065, ICI 45520, Ikopal, Inderal, Inderal LA, Inderalici, Inderex, Indermigran, Indobloc, Innopran, InnoPran XL, KEMI, Kidoral, Naprilin, Nedis, Nelderal, Noloten, Novopranol, NSC 91523, NSC-91523, Obsidan, Oposim, Panolol, Prandol, Pranix, Prano-Puren, Proberta LA, Procor, Pronovan, Propabloc, Propadex, Propalong, Propayerst, Prophylux, Propra vt ct, Proprahexal, Propral, Propranolol chloride, Propranolol HCl, Propranolol hydrochloride, Propranolol hydrochloride intensol, Propranovitan, Propranur, Propraratiopharm, Prosin, Pur-Bloka, Pylapron, R+C5989educor, Rapynogen, Sagittol, Sawatol, Scandrug, Sinal, Sloprolol, Sudenol, Tensiflex, Tesnol, Tiperal, Tonum, UNII-F8A3652H1V
  • SMILES: c12c(OCC(CNC(C)C)O)cccc1cccc2.Cl
  • AHFS Code: 24:24.0
  • InChl: 1S/C16H21NO2.ClH/c1-12(2)17-10-14(18)11-19-16-9-5-7-13-6-3-4-8-15(13)16;/h3-9,12,14,17-18H,10-11H2,1-2H3;1H
  • General Reference:

    1. Brunet A, Orr SP, Tremblay J, Robertson K, Nader K, Pitman RK: Effect of post-retrieval propranolol on psychophysiologic responding during subsequent script-driven traumatic imagery in post-traumatic stress disorder. J Psychiatr Res. 2007 Jun 21;. Pubmed
    2. Ohnishi ST, Sadanaga KK, Katsuoka M, Weidanz WP: Effects of membrane acting-drugs on plasmodium species and sickle cell erythrocytes. Mol Cell Biochem. 1989 Nov 23-Dec 19;91(1-2):159-65. Pubmed
    3. Singh N, Puri SK: Interaction between chloroquine and diverse pharmacological agents in chloroquine resistant Plasmodium yoelii nigeriensis. Acta Trop. 2000 Nov 2;77(2):185-93. Pubmed
    4. Murphy SC, Harrison T, Hamm HE, Lomasney JW, Mohandas N, Haldar K: Erythrocyte G protein as a novel target for malarial chemotherapy. PLoS Med. 2006 Dec;3(12):e528. Pubmed

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.

API’s From Quality Manufacturers:

  • Streamlined API supply towards initial research stages as well as larger quantities of cGMP material for clinical trials and product commercialization
  • Premium quality GMP certified and fully accredited API manufacturing plants


  • Technical packages as well as access to filed DMF,
    ASMF or CEP (subject to availability)
  • Regulatory and technical assistance towards any
    submission type based on specific customer requirements
This website uses cookies. By using our site, you agree to our terms of service